View Financial HealthBPH Global 배당 및 자사주 매입배당 기준 점검 0/6BPH Global 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-45.0%자사주 매입 수익률총 주주 수익률-45.0%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 3 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Paul Stephenson is the most experienced director on the board, commencing their role in 2020. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.공시 • Feb 13BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing공시 • Feb 05BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing공시 • Sep 19BPH Global Ltd, Annual General Meeting, Nov 14, 2025BPH Global Ltd, Annual General Meeting, Nov 14, 2025.공시 • Sep 17BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 250,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • May 02BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • Apr 28BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • Dec 31BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • Dec 17BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct ListingReported Earnings • Oct 03Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.016 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.016 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.98m (loss narrowed 49% from FY 2023).공시 • Oct 02BPH Global Ltd, Annual General Meeting, Nov 27, 2024BPH Global Ltd, Annual General Meeting, Nov 27, 2024.Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.018 loss in FY 2023)Full year 2024 results: AU$0.001 loss per share (improved from AU$0.018 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.60m (loss narrowed 63% from FY 2023).New Risk • Jul 31New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.5m free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Negative equity (-AU$244k). Earnings have declined by 19% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€476.1k market cap, or US$515.7k).공시 • Apr 11BPH Global Ltd. Announces Executive ChangesBPH Global Limited announced the appointment of Justyn Stedwell as Company Secretary. Justyn has over 17 years' experience as a Company Secretary of ASX listed companies and has also served as a Non-Executive Director on several ASX listed company Boards. He holds a Bachelor of Commerce from Monash University, a Graduate Diploma of Accounting from Deakin University and Graduate Diploma in Applied Corporate Governance from the Governance Institute of Australia. Further to this appointment, Belinda Cleminson and Shelby Coleman have resigned as joint CompanySecretaries.공시 • Jan 18BPH Global Ltd Announces Change of Joint Company SecretaryBPH Global Ltd. announced that Shelby Coleman has been appointed as Joint Company Secretary, effective immediately. Ms Coleman holds a Bachelor of Laws and a Bachelor of Arts from Victoria University of Wellington.She is experienced in ASX and ASIC compliance, providing advice on corporate governance and compliance issues as well as other regulatory maters. As a member of Automic Group's Company Secretary team, Ms Coleman assists a number of ASX listed, unlisted public and proprietary companies across a range of industries. Further to this appointment, Ms Elizabeth Spooner will step down as Joint Company Secretary effecve immediately. Ms Belinda Cleminson of Automic Group will continue in her role, being Joint Company Secretary.New Risk • Dec 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m (AU$339 revenue, or US$231). Market cap is less than US$10m (€1.59m market cap, or US$1.75m).공시 • Dec 12BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global Ltd (ASX:BP8) entered into an agreement to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners on September 20, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023. As of October 20, 2023, Completion of the acquisition is anticipated to occur 2 business days following the Company’s AGM on 21 November 2023 where shareholder approval for the issuance of shares to the vendors is being sought.BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners on December 11, 2023.공시 • Oct 20BPH Global Ltd, Annual General Meeting, Nov 21, 2023BPH Global Ltd, Annual General Meeting, Nov 21, 2023, at 16:00 AUS Eastern Standard Time. Location: at Automic offices at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To consider the Adoption of Remuneration Report; To consider the Election of Yanhua Huang as Director; To consider the Re-election of Huan Qing Gu as Director; To consider the ASX Listing Rule 7.1A Approval of Future Issue of Securities; To consider the Ratification of Prior Issue of Placement Shares; To consider the Approval of Issue of Placement Options; To consider the Approval of Issue of Options to Sanlam Private Wealth Pty Ltd; To consider the Approval of Issue of Shares and Options on conversion of 368,750 Convertible Notes; To consider the Approval of Issue of Shares and Options to Mr Paul Stephenson, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Francesco Cannavo, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Matthew Leonard, Director of the Company; and to consider other matters if any.Reported Earnings • Oct 05Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in FY 2022)Full year 2023 results: AU$0.004 loss per share (improved from AU$0.005 loss in FY 2022). Net loss: AU$4.26m (loss narrowed 20% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.공시 • Sep 21BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023.Reported Earnings • Sep 01Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022)Full year 2023 results: AU$0.003 loss per share. Net loss: AU$3.75m (loss widened 1.7% from FY 2022).New Risk • Aug 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.7m free cash flow). Share price has been highly volatile over the past 3 months (259% average daily change). Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (€1.56m market cap, or US$1.69m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (16% increase in shares outstanding).공시 • Jul 06BPH Global Ltd Appoints Michael Huang as Non-Executive DirectorThe Board of BPH Global Ltd. advised the appointment of Michael (Yanhua) Huang to the Board of Directors of the Company as a Non-Executive Director. Michael's return to the Board of BP8, marks a further consolidation of the Company' strategy to reinvigorate and further develop its bird's nest and dendrobium-infused bird's nest sales business in China (Bird's Nest Business). Michael Huang took the lead role on behalf of BP8 in conducting the pilot program in January and February this year. The pilot program trialled supply and distribution channels for the sale of bird's nest products via China Tobacco's outlets in Guangzhou and via social media influencers on Douyin, the China version of TikTok. Michael Huang brings his extensive experience and personal network in sales and marketing to the Board.공시 • May 12Stemcell United Limited Announces Board ChangesStemcell United Limited advised that Mr. Paul Rosen has tendered his resignation as a Non-Executive Director and Chairman, effective 12 May 2023.The Company announced the appointment of Mr. Paul Stephenson as independent non-executive Chair of the Board, effective immediately.Board Change • Apr 03No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Director Matthew Leonard was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 USZ0 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: USZ0 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장BPH Global 배당 수익률 vs 시장USZ0의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (USZ0)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.6%업계 평균 (Biotechs)2.4%분석가 예측 (USZ0) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 USZ0 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 USZ0 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 USZ0 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: USZ0 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/14 10:37종가2026/06/12 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스BPH Global Ltd는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Board Change • May 20Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 3 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Paul Stephenson is the most experienced director on the board, commencing their role in 2020. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
공시 • Feb 13BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing
공시 • Feb 05BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Transaction Features: Subsequent Direct Listing
공시 • Sep 19BPH Global Ltd, Annual General Meeting, Nov 14, 2025BPH Global Ltd, Annual General Meeting, Nov 14, 2025.
공시 • Sep 17BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 250,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,000,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • May 02BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • Apr 28BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 304,500,000 Price\Range: AUD 0.002 Discount Per Security: AUD 0.00012 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • Dec 31BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • Dec 17BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million.BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 41,666,667 Price\Range: AUD 0.003 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Reported Earnings • Oct 03Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.016 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.016 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.98m (loss narrowed 49% from FY 2023).
공시 • Oct 02BPH Global Ltd, Annual General Meeting, Nov 27, 2024BPH Global Ltd, Annual General Meeting, Nov 27, 2024.
Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.018 loss in FY 2023)Full year 2024 results: AU$0.001 loss per share (improved from AU$0.018 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.60m (loss narrowed 63% from FY 2023).
New Risk • Jul 31New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.5m free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Negative equity (-AU$244k). Earnings have declined by 19% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€476.1k market cap, or US$515.7k).
공시 • Apr 11BPH Global Ltd. Announces Executive ChangesBPH Global Limited announced the appointment of Justyn Stedwell as Company Secretary. Justyn has over 17 years' experience as a Company Secretary of ASX listed companies and has also served as a Non-Executive Director on several ASX listed company Boards. He holds a Bachelor of Commerce from Monash University, a Graduate Diploma of Accounting from Deakin University and Graduate Diploma in Applied Corporate Governance from the Governance Institute of Australia. Further to this appointment, Belinda Cleminson and Shelby Coleman have resigned as joint CompanySecretaries.
공시 • Jan 18BPH Global Ltd Announces Change of Joint Company SecretaryBPH Global Ltd. announced that Shelby Coleman has been appointed as Joint Company Secretary, effective immediately. Ms Coleman holds a Bachelor of Laws and a Bachelor of Arts from Victoria University of Wellington.She is experienced in ASX and ASIC compliance, providing advice on corporate governance and compliance issues as well as other regulatory maters. As a member of Automic Group's Company Secretary team, Ms Coleman assists a number of ASX listed, unlisted public and proprietary companies across a range of industries. Further to this appointment, Ms Elizabeth Spooner will step down as Joint Company Secretary effecve immediately. Ms Belinda Cleminson of Automic Group will continue in her role, being Joint Company Secretary.
New Risk • Dec 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m (AU$339 revenue, or US$231). Market cap is less than US$10m (€1.59m market cap, or US$1.75m).
공시 • Dec 12BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global Ltd (ASX:BP8) entered into an agreement to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners on September 20, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023. As of October 20, 2023, Completion of the acquisition is anticipated to occur 2 business days following the Company’s AGM on 21 November 2023 where shareholder approval for the issuance of shares to the vendors is being sought.BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners on December 11, 2023.
공시 • Oct 20BPH Global Ltd, Annual General Meeting, Nov 21, 2023BPH Global Ltd, Annual General Meeting, Nov 21, 2023, at 16:00 AUS Eastern Standard Time. Location: at Automic offices at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To consider the Adoption of Remuneration Report; To consider the Election of Yanhua Huang as Director; To consider the Re-election of Huan Qing Gu as Director; To consider the ASX Listing Rule 7.1A Approval of Future Issue of Securities; To consider the Ratification of Prior Issue of Placement Shares; To consider the Approval of Issue of Placement Options; To consider the Approval of Issue of Options to Sanlam Private Wealth Pty Ltd; To consider the Approval of Issue of Shares and Options on conversion of 368,750 Convertible Notes; To consider the Approval of Issue of Shares and Options to Mr Paul Stephenson, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Francesco Cannavo, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Matthew Leonard, Director of the Company; and to consider other matters if any.
Reported Earnings • Oct 05Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in FY 2022)Full year 2023 results: AU$0.004 loss per share (improved from AU$0.005 loss in FY 2022). Net loss: AU$4.26m (loss narrowed 20% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.
공시 • Sep 21BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million.BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023.
Reported Earnings • Sep 01Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022)Full year 2023 results: AU$0.003 loss per share. Net loss: AU$3.75m (loss widened 1.7% from FY 2022).
New Risk • Aug 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.7m free cash flow). Share price has been highly volatile over the past 3 months (259% average daily change). Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (€1.56m market cap, or US$1.69m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (16% increase in shares outstanding).
공시 • Jul 06BPH Global Ltd Appoints Michael Huang as Non-Executive DirectorThe Board of BPH Global Ltd. advised the appointment of Michael (Yanhua) Huang to the Board of Directors of the Company as a Non-Executive Director. Michael's return to the Board of BP8, marks a further consolidation of the Company' strategy to reinvigorate and further develop its bird's nest and dendrobium-infused bird's nest sales business in China (Bird's Nest Business). Michael Huang took the lead role on behalf of BP8 in conducting the pilot program in January and February this year. The pilot program trialled supply and distribution channels for the sale of bird's nest products via China Tobacco's outlets in Guangzhou and via social media influencers on Douyin, the China version of TikTok. Michael Huang brings his extensive experience and personal network in sales and marketing to the Board.
공시 • May 12Stemcell United Limited Announces Board ChangesStemcell United Limited advised that Mr. Paul Rosen has tendered his resignation as a Non-Executive Director and Chairman, effective 12 May 2023.The Company announced the appointment of Mr. Paul Stephenson as independent non-executive Chair of the Board, effective immediately.
Board Change • Apr 03No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Director Matthew Leonard was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.